AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2011
Oct 31, 2011
34117_dirs_2011-10-31_7fdc22df-b8cc-4709-a0c2-3b3761dde4a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-10-26
Reporting Person: LAROUNIS GEORGE P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-26 | Employee Stock Option | $0.17 | A | 60000 | Acquired | 2016-10-25 | Common Stock (60000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the Copytele, Inc. 2010 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6